Home » US FDA Foreign Inspections Better But Still Lag Behind Domestic
US FDA Foreign Inspections Better But Still Lag Behind Domestic
November 17, 2010
U.S. Food and Drug Administration (FDA) inspection of foreign plants has increased in recent years but still pales in comparison to the level of inspections made on U.S.-based manufacturing facilities, the U.S. Government Accountability Office (GAO) has found.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor